Indeed Snapshot

Track Vertex Pharmaceuticals reviews on Indeed to uncover insights on employee sentiment

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Profile Url Name Website Industry Description Revenue Headquarters location CEO Rating: CEO (%) Rating: CEO Responses Count Rating: Overall Happiness: Compensation score Happiness: Support score Happiness: Purpose score Happiness: Flexibility score Happiness: Energy score Happiness: Work Happiness score Happiness: Trust score Happiness: Learning score Happiness: Belonging score Happiness: Inclusion score Happiness: Overall score Happiness: Appreciation score Happiness: Achievement score Happiness: Responses Count Review Count Ratings Responses Count Rating: Culture & Values Rating: Compensation & Benefits Rating: Job Security & Advancement Rating: Senior Management Rating: Worklife Balance Interview: Duration Responses count Interview Duration Interview: Difficulty Responses count Interview Difficulty Interview: Experience Responses count Interview Experience Work Culture: Stressful (0) to Relaxed (1) Ratio Work Culture: Slow Paced (0) to Fast Paced (1) Ratio Work Culture: Competitive (0) to Collaborative (1) Ratio Date Added Date Updated Company Name Sector Industry
nasdaq:vrtx https://www.indeed.com/cmp/vertex-pharmaceuticals Aug 29th, 2022 12:00AM Open Vertex Pharmaceuticals Pharmaceutical & Biotechnology Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational small molecule medicines in other serious diseases where we have deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, we have a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus. Founded in 1989 in Cambridge, Mass., our global headquarters is now located in Boston's Innovation District and our international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes. RRv1_5B_10B 50 Northern Ave Boston, MA 02110 Reshma Kewalramani, M.D. 3.70 79.0 84.0 82.0 82.0 82.0 79.0 79.0 85.0 79.0 84.0 79.0 83.0 84.0 41.0 265.00 265.00 3.50 3.50 3.20 3.30 3.50 31.00 About a week 30.00 MEDIUM 30.00 AVERAGE Aug 29th, 2022 12:46PM Aug 29th, 2022 12:46PM Vertex Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vrtx https://www.indeed.com/cmp/vertex-pharmaceuticals Aug 28th, 2022 12:00AM Open Vertex Pharmaceuticals Pharmaceutical & Biotechnology Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational small molecule medicines in other serious diseases where we have deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, we have a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus. Founded in 1989 in Cambridge, Mass., our global headquarters is now located in Boston's Innovation District and our international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes. RRv1_5B_10B 50 Northern Ave Boston, MA 02110 Reshma Kewalramani, M.D. 3.70 79.0 84.0 82.0 82.0 82.0 79.0 79.0 85.0 79.0 84.0 83.0 84.0 41.0 265.00 265.00 3.50 3.50 3.20 3.30 3.50 31.00 About a week 30.00 MEDIUM 30.00 AVERAGE Aug 28th, 2022 05:47AM Aug 28th, 2022 05:47AM Vertex Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vrtx https://www.indeed.com/cmp/vertex-pharmaceuticals Aug 27th, 2022 12:00AM Open Vertex Pharmaceuticals Pharmaceutical & Biotechnology Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational small molecule medicines in other serious diseases where we have deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, we have a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus. Founded in 1989 in Cambridge, Mass., our global headquarters is now located in Boston's Innovation District and our international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes. RRv1_5B_10B 50 Northern Ave Boston, MA 02110 Reshma Kewalramani, M.D. 3.70 79.0 84.0 82.0 82.0 82.0 79.0 79.0 85.0 79.0 84.0 79.0 83.0 84.0 41.0 265.00 265.00 3.50 3.50 3.20 3.30 3.50 31.00 About a week 30.00 MEDIUM 30.00 AVERAGE Aug 27th, 2022 05:05AM Aug 27th, 2022 05:05AM Vertex Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vrtx https://www.indeed.com/cmp/vertex-pharmaceuticals Aug 25th, 2022 12:00AM Open Vertex Pharmaceuticals Pharmaceutical & Biotechnology Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational small molecule medicines in other serious diseases where we have deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, we have a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus. Founded in 1989 in Cambridge, Mass., our global headquarters is now located in Boston's Innovation District and our international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes. RRv1_5B_10B 50 Northern Ave Boston, MA 02110 Reshma Kewalramani, M.D. 3.70 79.0 84.0 82.0 82.0 82.0 79.0 79.0 85.0 79.0 84.0 79.0 83.0 84.0 41.0 265.00 265.00 3.50 3.50 3.20 3.30 3.50 31.00 About a week 30.00 MEDIUM 30.00 AVERAGE Aug 25th, 2022 09:45AM Aug 25th, 2022 09:45AM Vertex Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vrtx https://www.indeed.com/cmp/vertex-pharmaceuticals Aug 23rd, 2022 12:00AM Open Vertex Pharmaceuticals Pharmaceutical & Biotechnology Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational small molecule medicines in other serious diseases where we have deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, we have a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus. Founded in 1989 in Cambridge, Mass., our global headquarters is now located in Boston's Innovation District and our international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes. RRv1_5B_10B 50 Northern Ave Boston, MA 02110 Reshma Kewalramani, M.D. 3.70 79.0 84.0 82.0 82.0 82.0 79.0 79.0 85.0 79.0 84.0 79.0 83.0 84.0 41.0 265.00 265.00 3.50 3.50 3.20 3.30 3.50 31.00 About a week 30.00 MEDIUM 30.00 AVERAGE Aug 23rd, 2022 11:38AM Aug 23rd, 2022 11:38AM Vertex Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vrtx https://www.indeed.com/cmp/vertex-pharmaceuticals Aug 21st, 2022 12:00AM Open Vertex Pharmaceuticals Pharmaceutical & Biotechnology Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational small molecule medicines in other serious diseases where we have deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, we have a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus. Founded in 1989 in Cambridge, Mass., our global headquarters is now located in Boston's Innovation District and our international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes. RRv1_5B_10B 50 Northern Ave Boston, MA 02110 Reshma Kewalramani, M.D. 3.70 79.0 84.0 82.0 82.0 82.0 79.0 79.0 85.0 79.0 84.0 79.0 83.0 84.0 41.0 265.00 265.00 3.50 3.50 3.20 3.30 3.50 31.00 About a week 30.00 MEDIUM 30.00 AVERAGE Aug 21st, 2022 01:22PM Aug 21st, 2022 01:22PM Vertex Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vrtx https://www.indeed.com/cmp/vertex-pharmaceuticals Aug 20th, 2022 12:00AM Open Vertex Pharmaceuticals Pharmaceutical & Biotechnology Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational small molecule medicines in other serious diseases where we have deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, we have a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus. Founded in 1989 in Cambridge, Mass., our global headquarters is now located in Boston's Innovation District and our international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes. RRv1_5B_10B 50 Northern Ave Boston, MA 02110 Reshma Kewalramani, M.D. 3.70 79.0 84.0 82.0 82.0 82.0 79.0 79.0 85.0 79.0 84.0 83.0 84.0 41.0 265.00 265.00 3.50 3.50 3.20 3.30 3.50 31.00 About a week 30.00 MEDIUM 30.00 AVERAGE Aug 20th, 2022 03:01PM Aug 20th, 2022 03:01PM Vertex Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vrtx https://www.indeed.com/cmp/vertex-pharmaceuticals Aug 19th, 2022 12:00AM Open Vertex Pharmaceuticals Pharmaceutical & Biotechnology Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational small molecule medicines in other serious diseases where we have deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, we have a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus. Founded in 1989 in Cambridge, Mass., our global headquarters is now located in Boston's Innovation District and our international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes. RRv1_5B_10B 50 Northern Ave Boston, MA 02110 Reshma Kewalramani, M.D. 3.70 79.0 84.0 82.0 82.0 82.0 79.0 79.0 85.0 79.0 84.0 79.0 83.0 84.0 41.0 265.00 265.00 3.50 3.50 3.20 3.30 3.50 31.00 About a week 30.00 MEDIUM 30.00 AVERAGE Aug 19th, 2022 01:22PM Aug 19th, 2022 01:22PM Vertex Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vrtx https://www.indeed.com/cmp/vertex-pharmaceuticals Aug 18th, 2022 12:00AM Open Vertex Pharmaceuticals Pharmaceutical & Biotechnology Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational small molecule medicines in other serious diseases where we have deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, we have a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus. Founded in 1989 in Cambridge, Mass., our global headquarters is now located in Boston's Innovation District and our international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes. RRv1_5B_10B 50 Northern Ave Boston, MA 02110 Reshma Kewalramani, M.D. 3.70 79.0 84.0 82.0 82.0 82.0 79.0 79.0 85.0 79.0 84.0 79.0 83.0 84.0 41.0 265.00 265.00 3.50 3.50 3.20 3.30 3.50 31.00 About a week 30.00 MEDIUM 30.00 AVERAGE Aug 18th, 2022 05:09AM Aug 18th, 2022 05:09AM Vertex Pharmaceuticals Health Care Pharmaceuticals & Biotechnology
nasdaq:vrtx https://www.indeed.com/cmp/vertex-pharmaceuticals Aug 17th, 2022 12:00AM Open Vertex Pharmaceuticals Pharmaceutical & Biotechnology Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. We have multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — a rare, life-threatening genetic disease — and several ongoing clinical and research programs in CF. Beyond CF, we have a robust pipeline of investigational small molecule medicines in other serious diseases where we have deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency and APOL1-mediated kidney diseases. In addition, we have a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus. Founded in 1989 in Cambridge, Mass., our global headquarters is now located in Boston's Innovation District and our international headquarters is in London, UK. Additionally, we have research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 10 consecutive years on Science magazine's Top Employers list and top five on the 2019 Best Employers for Diversity list by Forbes. RRv1_5B_10B 50 Northern Ave Boston, MA 02110 Reshma Kewalramani, M.D. 3.70 79.0 84.0 82.0 82.0 82.0 79.0 79.0 85.0 79.0 84.0 83.0 84.0 41.0 265.00 265.00 3.50 3.50 3.20 3.30 3.50 31.00 About a week 30.00 MEDIUM 30.00 AVERAGE Aug 17th, 2022 10:44AM Aug 17th, 2022 10:44AM Vertex Pharmaceuticals Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.